“KLEAR-PDT: Photodynamic Therapy for Basal Cell Carcinomas in Gorlin Syndrome Using Skin-Clearing Agents ”
Kavita Sarin, M.D., Ph.D., Principal Investigator
Stanford University School of Medicine
Professor of Dermatology, Director, Skin Cancer Genetics Program.
2025
“Gorlin Syndrome Beyond PTCH1 and SUFU: Leave No Patients Undiagnosed”
Barbara Rivera Polo, PhD, Principal Investigator
Bellvitge Biomedical Research Institute (IDIBELL)
Miguel Servet Fellow at the Rare Tumors Lab – Hereditary Cancer Programme
2024
“Defining the BCC microenvironment change in response to smoothened inhibition: Identification of a role for addition of checkpoint inhibitor to optimize antitumor therapy for overwhelming disease.”
.jpg?width=250&name=1578553822%20(1).jpg "1578553822 (1)")
%20(2).png?width=150&height=64&name=GSA%20Logo%20High%20Res%20No%20Background%20(1)%20(2).png)
%20(2)-1.png?width=200&height=85&name=GSA%20Logo%20High%20Res%20No%20Background%20(1)%20(2)-1.png)